European Union authorities on Monday stepped in to effectively ban sales of blood pressure medicine valsartan made by an India-based unit of Mylan NV after some batches were found to contain a probable cancer-causing impurity, the latest in a global crackdown.
from Reuters: Health News https://ift.tt/2PFxoyS
via
IFTTT
0 comments:
Post a Comment